Compound heterozygosity with a novel S222N GALT mutation leads to atypical galactosemia with loss of GALT activity in erythrocytes but little evidence of clinical disease

Benjamin Cocanougher, Umut Aypar, Amber McDonald, Linda Hasadsri, Michael J. Bennett, W Edward Jr. Highsmith, Kristin D'Aco

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Galactosemia is an inborn error of galactose metabolism caused by mutations in the GALT gene. Though early detection and galactose restriction prevent severe liver disease, affected individuals have persistently elevated biomarkers and often neuro-developmental symptoms. We present a teenage compound heterozygote for a known pathogenic mutation (H132Q) and a novel variant of unknown significance (S222N), with nearly absent erythrocyte GALT enzyme activity but normal biomarkers and only mild anxiety despite diet non-adherence. This case is similar to a previously reported S135L mutation. In this report we investigate the novel S222N variant and critically evaluate a clinically puzzling case.

Original languageEnglish (US)
Pages (from-to)61-64
Number of pages4
JournalMolecular Genetics and Metabolism Reports
Volume2
DOIs
StatePublished - 2015

Fingerprint

Galactosemias
Erythrocytes
Galactose
Mutation
Biomarkers
Inborn Errors Metabolism
Heterozygote
Liver Diseases
Anxiety
Diet
Enzymes
Genes

Keywords

  • Diagnosis
  • Galactosemia
  • Pathogenesis

ASJC Scopus subject areas

  • Endocrinology
  • Genetics
  • Molecular Biology

Cite this

Compound heterozygosity with a novel S222N GALT mutation leads to atypical galactosemia with loss of GALT activity in erythrocytes but little evidence of clinical disease. / Cocanougher, Benjamin; Aypar, Umut; McDonald, Amber; Hasadsri, Linda; Bennett, Michael J.; Highsmith, W Edward Jr.; D'Aco, Kristin.

In: Molecular Genetics and Metabolism Reports, Vol. 2, 2015, p. 61-64.

Research output: Contribution to journalArticle

Cocanougher, Benjamin ; Aypar, Umut ; McDonald, Amber ; Hasadsri, Linda ; Bennett, Michael J. ; Highsmith, W Edward Jr. ; D'Aco, Kristin. / Compound heterozygosity with a novel S222N GALT mutation leads to atypical galactosemia with loss of GALT activity in erythrocytes but little evidence of clinical disease. In: Molecular Genetics and Metabolism Reports. 2015 ; Vol. 2. pp. 61-64.
@article{a8ee74ba1e0f41d58beab218bba9cdb9,
title = "Compound heterozygosity with a novel S222N GALT mutation leads to atypical galactosemia with loss of GALT activity in erythrocytes but little evidence of clinical disease",
abstract = "Galactosemia is an inborn error of galactose metabolism caused by mutations in the GALT gene. Though early detection and galactose restriction prevent severe liver disease, affected individuals have persistently elevated biomarkers and often neuro-developmental symptoms. We present a teenage compound heterozygote for a known pathogenic mutation (H132Q) and a novel variant of unknown significance (S222N), with nearly absent erythrocyte GALT enzyme activity but normal biomarkers and only mild anxiety despite diet non-adherence. This case is similar to a previously reported S135L mutation. In this report we investigate the novel S222N variant and critically evaluate a clinically puzzling case.",
keywords = "Diagnosis, Galactosemia, Pathogenesis",
author = "Benjamin Cocanougher and Umut Aypar and Amber McDonald and Linda Hasadsri and Bennett, {Michael J.} and Highsmith, {W Edward Jr.} and Kristin D'Aco",
year = "2015",
doi = "10.1016/j.ymgmr.2014.12.004",
language = "English (US)",
volume = "2",
pages = "61--64",
journal = "Molecular Genetics and Metabolism Reports",
issn = "2214-4269",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Compound heterozygosity with a novel S222N GALT mutation leads to atypical galactosemia with loss of GALT activity in erythrocytes but little evidence of clinical disease

AU - Cocanougher, Benjamin

AU - Aypar, Umut

AU - McDonald, Amber

AU - Hasadsri, Linda

AU - Bennett, Michael J.

AU - Highsmith, W Edward Jr.

AU - D'Aco, Kristin

PY - 2015

Y1 - 2015

N2 - Galactosemia is an inborn error of galactose metabolism caused by mutations in the GALT gene. Though early detection and galactose restriction prevent severe liver disease, affected individuals have persistently elevated biomarkers and often neuro-developmental symptoms. We present a teenage compound heterozygote for a known pathogenic mutation (H132Q) and a novel variant of unknown significance (S222N), with nearly absent erythrocyte GALT enzyme activity but normal biomarkers and only mild anxiety despite diet non-adherence. This case is similar to a previously reported S135L mutation. In this report we investigate the novel S222N variant and critically evaluate a clinically puzzling case.

AB - Galactosemia is an inborn error of galactose metabolism caused by mutations in the GALT gene. Though early detection and galactose restriction prevent severe liver disease, affected individuals have persistently elevated biomarkers and often neuro-developmental symptoms. We present a teenage compound heterozygote for a known pathogenic mutation (H132Q) and a novel variant of unknown significance (S222N), with nearly absent erythrocyte GALT enzyme activity but normal biomarkers and only mild anxiety despite diet non-adherence. This case is similar to a previously reported S135L mutation. In this report we investigate the novel S222N variant and critically evaluate a clinically puzzling case.

KW - Diagnosis

KW - Galactosemia

KW - Pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=84923230024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923230024&partnerID=8YFLogxK

U2 - 10.1016/j.ymgmr.2014.12.004

DO - 10.1016/j.ymgmr.2014.12.004

M3 - Article

VL - 2

SP - 61

EP - 64

JO - Molecular Genetics and Metabolism Reports

JF - Molecular Genetics and Metabolism Reports

SN - 2214-4269

ER -